Royalty Report: Consumer Goods, Retail & Leisure, Personal Care – Collection: 146138

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Consumer Goods
  • Retail & Leisure
  • Personal Care
  • Dermatology
  • Skin care
  • Beauty Aid
  • Sunscreen
  • Specialty

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 146138

License Grant
The Licensee has a Products Supply and License Agreement with the Licensor, the owner of the Complex 272 formula.  Pursuant to the Agreement, the Licensee has an exclusive license to use Complex 272 in skin care products.
License Property
Complex 272 – is a saponin complex used in skin chemical peels.
Field of Use
Specialty pharmaceutical company that develops, markets and sells products for physician-mediated skin health and restoration.

IPSCIO Record ID: 257089

License Grant
In connection with the acquisition agreement, the Licensee entered into a Related Party Agreement with one of our directors and beneficial shareholders, the Licensor.  The Licensee is obligated to pay an annual royalty to the Licensor on sales of non-prescription products that were in development at the time of the acquisition. The products are in the field of skin health and restoration. The Agreement includes a trademark and trade name license agreement with the Licensor, to use the trademarks and trade names 'Obagi' in connection with the Companys sale of skin care products.
License Property
Trademarks and trade names 'Obagi' (skin care products).
Field of Use
The Licensee is a specialty pharmaceutical company that develops, markets and sells products for physician-mediated skin health and restoration.

IPSCIO Record ID: 203653

License Grant
The Israeli Licensee received from the Israeli Licensor, the technology transfer company of the University, an exclusive and a non-exclusive license for the commercialization of certain Licensor patents.
License Property
The Licensee has a proprietary method of entrapping the active ingredients of sunscreen molecules in silica glass beads to prevent direct contact with the skin and absorption into the body, based upon the licensed patents.

With the technology, each chemical that absorbs ultraviolet sun radiation is trapped into a separate minute micron-sized bead-like particle of glass. The particles are small enough to be incorporated into a variety of cosmetic preparations, including moisturizer, lipstick and body lotion.

Field of Use
The Israeli Licensee is a clinical-stage specialty pharmaceutical company, focusing on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system.

Licensee's product will be used in other cosmetic products, such as moisturizer, lipstick, and body lotion.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.